ArticleKidney medicine2025

Obinutuzumab, an Anti-CD20, in Refractory Adult Autoimmune Podocytopathies: Report of 2 Cases.

Thomas Loeffler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.